556 related articles for article (PubMed ID: 22849734)
41. Diffuse large B-cell lymphoma variants: an update.
Sukswai N; Lyapichev K; Khoury JD; Medeiros LJ
Pathology; 2020 Jan; 52(1):53-67. PubMed ID: 31735345
[TBL] [Abstract][Full Text] [Related]
42. Primary cutaneous lymphoma associated with Epstein-Barr virus and azathioprine therapy.
McAleer MA; D'Arcy CA; Mulligan NJ; Sheahan K; Collins P
Clin Exp Dermatol; 2010 Aug; 35(6):674-6. PubMed ID: 20345996
[No Abstract] [Full Text] [Related]
43. Co-infection of human herpesvirus-6 and human herpesvirus-8 in primary cutaneous diffuse large B-cell lymphoma, leg type.
Nakayama-Ichiyama S; Yokote T; Iwaki K; Miyoshi T; Takubo T; Tsuji M; Hanafusa T
Br J Haematol; 2011 Nov; 155(4):514-6. PubMed ID: 21517824
[No Abstract] [Full Text] [Related]
44. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.
Wobser M; Kneitz H; Bröcker EB; Becker JC
J Dtsch Dermatol Ges; 2011 Mar; 9(3):204-11. PubMed ID: 21122066
[TBL] [Abstract][Full Text] [Related]
45. [Cutaneous B-cell lymphoma].
Cortés B; Prins C
Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
[TBL] [Abstract][Full Text] [Related]
46. Cutaneous diffuse large B-cell lymphoma of the leg associated with chronic lymphedema.
González-Vela MC; González-López MA; Val-Bernal JF; Fernández-Llaca H
Int J Dermatol; 2008 Feb; 47(2):174-7. PubMed ID: 18211492
[TBL] [Abstract][Full Text] [Related]
47. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract][Full Text] [Related]
48. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.
van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ
J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125
[TBL] [Abstract][Full Text] [Related]
49. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
50. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
[TBL] [Abstract][Full Text] [Related]
51. Intravascular large B-cell lymphoma with cutaneous manifestations: a clinicopathologic, immunophenotypic and molecular study of three cases.
Kong YY; Dai B; Sheng WQ; Yang WT; Wang CF; Kong JC; Shi DR
J Cutan Pathol; 2009 Aug; 36(8):865-70. PubMed ID: 19040469
[TBL] [Abstract][Full Text] [Related]
52. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
53. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and Management of Cutaneous B-cell Lymphoma.
Pinter-Brown LC
Dermatol Clin; 2015 Oct; 33(4):835-40. PubMed ID: 26433853
[TBL] [Abstract][Full Text] [Related]
55. Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome.
Nakayama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Miyoshi T; Oka S; Hiraoka N; Iwaki K; Takayama A; Takubo T; Tsuji M; Hanafusa T
Eur J Haematol; 2010 Jan; 84(1):79-83. PubMed ID: 19558504
[TBL] [Abstract][Full Text] [Related]
56. Primary cutaneous B-cell lymphoma: classification and treatment.
Willemze R
Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
[TBL] [Abstract][Full Text] [Related]
57. Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab.
Nagasaka A; Matsue H; Kawamura T; Kanzaki M; Inozume T; Nakamura Y; Shimzu A; Shibagaki N; Yanagi M; Shimada S
J Dermatol; 2006 May; 33(5):377-9. PubMed ID: 16700675
[No Abstract] [Full Text] [Related]
58. An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature.
Tsang HC; Mathew S; Magro CM
Am J Dermatopathol; 2017 Mar; 39(3):e44-e49. PubMed ID: 27759694
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop.
Swerdlow SH; Quintanilla-Martinez L; Willemze R; Kinney MC
Am J Clin Pathol; 2013 Apr; 139(4):515-35. PubMed ID: 23525619
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]